KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Account Payables: 2010-2024

Historic Change in Account Payables for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $231,000.

  • TherapeuticsMD's Change in Account Payables fell 195.60% to -$87,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $29,000, marking a year-over-year increase of 106.28%. This contributed to the annual value of $231,000 for FY2024, which is 110.82% up from last year.
  • TherapeuticsMD's Change in Account Payables amounted to $231,000 in FY2024, which was up 110.82% from -$2.1 million recorded in FY2023.
  • TherapeuticsMD's Change in Account Payables' 5-year high stood at $1.9 million during FY2020, with a 5-year trough of -$2.1 million in FY2023.
  • Over the past 3 years, TherapeuticsMD's median Change in Account Payables value was -$1.2 million (recorded in 2022), while the average stood at -$1.0 million.
  • As far as peak fluctuations go, TherapeuticsMD's Change in Account Payables skyrocketed by 152.96% in 2020, and later slumped by 156.28% in 2021.
  • Over the past 5 years, TherapeuticsMD's Change in Account Payables (Yearly) stood at $1.9 million in 2020, then plummeted by 156.28% to -$1.1 million in 2021, then declined by 14.03% to -$1.2 million in 2022, then tumbled by 76.30% to -$2.1 million in 2023, then skyrocketed by 110.82% to $231,000 in 2024.